Literature DB >> 21036393

Drug harms in the UK: a multicriteria decision analysis.

David J Nutt1, Leslie A King, Lawrence D Phillips.   

Abstract

BACKGROUND: Proper assessment of the harms caused by the misuse of drugs can inform policy makers in health, policing, and social care. We aimed to apply multicriteria decision analysis (MCDA) modelling to a range of drug harms in the UK.
METHODS: Members of the Independent Scientific Committee on Drugs, including two invited specialists, met in a 1-day interactive workshop to score 20 drugs on 16 criteria: nine related to the harms that a drug produces in the individual and seven to the harms to others. Drugs were scored out of 100 points, and the criteria were weighted to indicate their relative importance.
FINDINGS: MCDA modelling showed that heroin, crack cocaine, and metamfetamine were the most harmful drugs to individuals (part scores 34, 37, and 32, respectively), whereas alcohol, heroin, and crack cocaine were the most harmful to others (46, 21, and 17, respectively). Overall, alcohol was the most harmful drug (overall harm score 72), with heroin (55) and crack cocaine (54) in second and third places.
INTERPRETATION: These findings lend support to previous work assessing drug harms, and show how the improved scoring and weighting approach of MCDA increases the differentiation between the most and least harmful drugs. However, the findings correlate poorly with present UK drug classification, which is not based simply on considerations of harm. FUNDING: Centre for Crime and Justice Studies (UK).
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21036393     DOI: 10.1016/S0140-6736(10)61462-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  259 in total

1.  Hypocretin receptor 2 antagonism dose-dependently reduces escalated heroin self-administration in rats.

Authors:  Brooke E Schmeichel; Estelle Barbier; Kaushik K Misra; Candice Contet; Joel E Schlosburg; Dimitri Grigoriadis; John P Williams; Camilla Karlsson; Caleb Pitcairn; Markus Heilig; George F Koob; Leandro F Vendruscolo
Journal:  Neuropsychopharmacology       Date:  2015-03-13       Impact factor: 7.853

2.  "I'm not afraid of those ones just 'cause they've been prescribed": perceptions of risk among illicit users of pharmaceutical opioids.

Authors:  Raminta Daniulaityte; Russel Falck; Robert G Carlson
Journal:  Int J Drug Policy       Date:  2012-03-13

3.  General practitioners' strategies to identify alcohol problems: a focus group study.

Authors:  Torgeir Gilje Lid; Kirsti Malterud
Journal:  Scand J Prim Health Care       Date:  2012-06       Impact factor: 2.581

4.  Treatment outcomes for veterans with PTSD and substance use: Impact of specific substances and achievement of abstinence.

Authors:  Ajay Manhapra; Elina Stefanovics; Robert Rosenheck
Journal:  Drug Alcohol Depend       Date:  2015-09-25       Impact factor: 4.492

5.  Cannabis legalization: adhering to public health best practice.

Authors:  Sheryl Spithoff; Brian Emerson; Andrea Spithoff
Journal:  CMAJ       Date:  2015-09-21       Impact factor: 8.262

6.  Perceived Risk of Heroin in Relation to Other Drug Use in a Representative US Sample.

Authors:  Joseph J Palamar; Austin Le; Pedro Mateu-Gelabert
Journal:  J Psychoactive Drugs       Date:  2019-06-22

Review 7.  The gut in the brain: the effects of bariatric surgery on alcohol consumption.

Authors:  Ashley N Blackburn; Andras Hajnal; Lorenzo Leggio
Journal:  Addict Biol       Date:  2016-08-31       Impact factor: 4.280

8.  Alcohol use disorders and antiretroviral therapy among prisoners in Argentina.

Authors:  Michael Alpert; Jeffrey A Wickersham; Mariana Vázquez; Frederick L Altice
Journal:  Int J Prison Health       Date:  2013

9.  GDNF and alcohol use disorder.

Authors:  Segev Barak; Somayeh Ahmadiantehrani; Marian L Logrip; Dorit Ron
Journal:  Addict Biol       Date:  2018-05-04       Impact factor: 4.280

10.  Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences.

Authors:  Theresa M Carbonaro; Matthew P Bradstreet; Frederick S Barrett; Katherine A MacLean; Robert Jesse; Matthew W Johnson; Roland R Griffiths
Journal:  J Psychopharmacol       Date:  2016-08-30       Impact factor: 4.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.